Submitting Continuing Reviews and/or Amendments to the IRB
|
|
- Violet Young
- 6 years ago
- Views:
Transcription
1 Submitting Continuing Reviews and/or Amendments to the IRB Tufts-New England Medical Center Tufts University Health Sciences IRB Education Series 2006 Presentation may only be reused or reprinted with written permission from the Tufts-New England Medical Center/Tufts University IRB office.
2 What is continuing review? Periodic review of research previously approved by the IRB According to federal law the IRB must conduct continuing review at intervals appropriate to the degree of risk, but not less than once per year (45 CFR (e)) Also according to federal law the IRB may observe or have third party observe the consent process and the research. (45 CFR (e))
3 and why is it important? On going assessment of the research: Subject safety Compliance with the protocol Update of adverse events Propose amendments Revise and update study documents
4 Regulatory Interpretation Issued by the Government The regulations make no provision for any grace period extending the conduct of research beyond the expiration date of IRB approval.... Source: OHRP Compliance Activities: Common Findings and Guidance 9/1/2000 (Compliance Oversight Branch Division of Human Subjects Protection, OHRP) Please note that when continuing review does not occur by the date specified by the IRB, IRB approval expires automatically. [emphasis in original] Source: Letter to the University of Oklahoma Health Sciences Center, Michael Carome, M.D., OHRP Director, Division of Compliance Oversight in a letter dated October 19, 2000.
5 What does the IRB Consider at CR? Review is expected to be as rigorous as initial review Application of the Belmont Report Respect for Persons Informed consent Voluntary participation Freedom to withdraw from a study without penalty Protect privacy and confidentiality Beneficence Risks are minimized Benefits are maximized Risks are justified by potential benefits Conflicts of interest are managed or eliminated Justice Protection of vulnerable populations Those who may benefit are not excluded
6 Type of Review: Expedited or Full Studies initially granted expedited approval may qualify for expedited CR if there have been no changes to the research. Studies initially approved by full IRB review may be expedited if: The research is permanently closed to the enrollment of new subjects; All subjects have completed all research related interventions; and; The research remains active only for long-term follow-up of subjects; No subjects have been enrolled and no additional risks have been identified; The remaining research activities are limited to data analysis; The IRB determined and documented at a convened meeting that the research involves no greater than minimal risk and no additional risks have been identified.
7 Expedited or Full: How Is It Decided? Determined in IRB office, based on: Federal guidance Discretion of reviewer IRB office will process based on above.
8 Continuing Review Applications if the Study is Open to Enrollment (Full IRB Review) Form V Protocol current version ICF(s) version used over the past year, current copy Education requirements satisfied Advertisement(s) Questionnaire(s) Form II (drug/compound) Form III (device) Form IV (research radiation) Form VI (tissue-banking) Optional TB ICF HIPAA documentation
9 FORM V Submit an original and TWO (2) copies of all documentation (protocol, ICF(s), Forms II, III, IV, VI, as applicable, and all necessary supporting documentation) to the IRB office, Box 817. Please ensure that at least one set of copies is singlesided. If you wish to terminate a study (or close a completed study) because no further work will be done or if the study was never initiated please submit a Termination letter. This, and all forms submitted to the IRB office, should be typed.
10 FORM V D. Mandatory Human Subject Protection Education Especially important if new research team members have been added (remember to revise other documents: protocol, ICF, etc.) The completion of the education modules is mandatory for each research team member. Research Team Members: Those who are responsible for the design, conduct, or reporting of this research, such as the Principal and Co-Investigators, Research Nurses and Coordinators, Project Managers, etc. Based on an individual s role (e.g., Co-I, coordinator) Education requirements and modules are accessible at:
11 OHRP Investigator 101 Barnes lectures Education Modules September lecture, Research Compliance: Basic Requirements and Accurate Record Keeping October lecture, Recognizing and Reporting Adverse Events During a Clinical Trial November lecture, The Impact of HIPAA on Clinical Research; OR lecture given by Steven D. Schwaitzberg, MD, A Practical Guide to HIPAA Issues for Research at T-NEMC and TUHS December lecture, What Researchers need to Know about Investigational Drugs and Devices under FDA Regulations (INDs/IDEs)
12 FORM V F. Subject Population Do you wish to request additional subjects: Yes No If yes: submit a revised protocol. Number of subjects enrolled since the last continuing review (if applicable): Total number of subjects enrolled to date (since study initiated): In the past year, have any subjects withdrawn their participation from the study? Yes No Briefly state the reason. In the past year, have any subjects been withdrawn by the PI or Sponsor? Yes No Briefly state the reason. Number of subjects that are being followed (if applicable):
13 FORM V J. Status Report: Has this research changed in any way since the last continuing review? Yes No If Yes, itemize the changes that have been approved. Are there revisions or changes that are being submitted with this application? Yes No Please attach a summary of any amendments, revisions, modifications to the research since the last review; any relevant multi-trial reports, any relevant recent literature, interim findings, or any other relevant information associated with the research.
14 FORM V K. Serious Adverse or Unanticipated Events Have there been any serious adverse events or unanticipated events at Tufts-NEMC/TUHS? Yes No If yes, attach a spread sheet or chart and address the events by itemizing all serious adverse events or unanticipated events that have occurred involving this research protocol since the initial review or the most recent continuing review. Does this research study have a Data and Safety Monitoring Board? Yes No If yes, attach the most recent DSMB report (if available).
15 Advertisements and Questionnaires All ads, questionnaires, pamphlets, summaries, etc., must be reviewed and approved by the IRB at CR All documents approved for use will be validated (stamped).
16 FORM II For any drug, substance, or biologic administered as part of the research. Don t leave ANY blank fields N/A Need the: Investigator s Brochure Package insert information don t send the actual insert! Micromedex printout MSDS sheets Reason for submission: updates, new information, etc.
17 FORM III For any device used as part of the research. Don t leave ANY blank fields N/A If there is FDA correspondence/documentation, submit a copy Need the: Investigator s Brochure Operator's Manual User s Guide Reason for submission: updates, new information, etc.
18 FORM IV For any radiation exposure as part of the research. X-ray CT scan Fluoroscopy PET scan Nuclear medicine scan Only needs to be submitted if there has been a change in research-related radiation exposure since last approval by the Radiation Safety Officer (RSO). If there hasn t been a change in research-related exposure, submit a cover letter signed by the Principal Investigator stating such and a copy of the last RSO signed Form IV. If a revised form is submitted it must be signed by the Radiation Safety Officer
19 For any sample banking FORM VI Submit a copy of the tissue bank's written policies A copy of the optional tissue banking ICF version used over the last year version to be validated
20 HIPAA Documentation Copy of the RAF or a letter signed by the PI that there have been no changes If a waiver was previously granted and < 50 records reviewed, etc: names > 50 records reviewed, etc: profile Submit names/profile to the HIPAA Privacy Officer for Research Jeffrey Weinstein (Tufts-NEMC) XXX (TUSDM)
21 If the Research is Closed to Enrollment (Original and 2 copies) Form V Protocol ICF(s) if anyone was enrolled in the past year Education requirements satisfied Questionnaire(s), or any other document(s) still being administered/used
22 Submitted: Reviewed for: Completeness Education requirements Conflict of Interest Info Accordance with federal and state regulations and institutional policies
23 Reviewed by the Full IRB Assigned to an IRB agenda Reviewer Assigned Reviewed at a convened IRB meeting IRB letter sent to PI within 2 weeks of the meeting if changes/clarifications are needed Approval letter is generated, signed, and sent to the PI.
24 Principal Investigator responds to IRB review requests for clarification/change: Submission is reviewed by expedited review procedures unless it s stipulated that it must return to the convened IRB If necessary, additional information, etc., is requested from the PI. Approval letter is generated, signed, and sent to the PI. IRB members are notified.
25 What If IRB Approval Lapses? Don t let it happen! Courtesy reminders are sent to the Principal Investigator If CR doesn't take place and IRB approval lapses, the research must stop all aspects (including follow-up and data analysis) The IRB will assess the medical interests of individual subjects and may determine interventions or interactions can continue (very limited circumstances). Enrollment of new subjects cannot occur after the expiration of IRB approval.
26 Amendments At Continuing Review Kills 2 birds with 1 stone Submit tracked and untracked copies of all documents Submit a detailed letter signed by the PI Explain rationale/need for changes New safety information Additional (or deleted) procedures Explain who initiated changes PI? Sponsor?
27 Continuing Review Common Problems Incomplete submission missing copies/documents ICF too technical or missing elements Required documents not provided Forms not complete or inaccurate/conflicting info on forms Signature of PI not provided Education requirements are not satisfied COI information is missing
28 Helpful Tips When Submitting Continuing Reviews Re-review ICF prior to submission Write ICF at an 8 th grade reading level. Address all issues if changes/clarifications are requested PI signatures present as required. If applicable, provide a copy of the grant. Provide requisite supporting documentation. Provide tracked and untracked copies of revised documents. Ensure all documents have a version date or number. Ensure education requirements are satisfied. Re-read information entered on the forms
29 Amendments Between Reviews Submit a detailed letter signed by the PI Explain rationale/need for changes New safety information SAE Additional (or deleted) procedures DSMB report/interim analysis Explain who initiated changes PI? Sponsor? Submit tracked and untracked copies of all documents
30 Things to Consider When Submitting Amendments Do study documents need to be revised? Protocol ICF Advertisements Which, if any, subjects does the amendment effect? Prospective/new subjects Those already enrolled and actively receiving intervention Those enrolled in the study no longer receiving intervention but still being followed? Detail the plan for notifying subjects Will everyone re-consent?
31 Common Problems With Amendments Incomplete submission Cover letter only revised protocol not provided Documents requiring revision (ICF, ads, questionnaires) not submitted Revised documents are too technical Signature of PI not provided Required documents not provided
32 More Information OHRP: Guidance on Continuing Review (copy provided) Code of Federal Regulations ICF Tips FDA:
33 IRB Leadership IRB Chair: David P. Chelmow, MD IRB Vice-Chairs: Edward L. Decker, PharmD Judith A. Frazier, RN, MEd Nicholas G. Guerina, MD, PhD IRB Members are from more than 17 divisions at Tufts-NEMC and Tufts University, including TUSM, TUSDM, HNRCA, etc., and community representatives who are not affiliated with either institution.
34 IRB office IRB Admin. and Operations Manager: Jennifer A. Graf IRB Coordinators: Julie Morelli Novak (IRB-RED) Elizabeth Kervis (IRB-BLUE) Continuing Review Coordinators: André Briola TBA Assistant IRB Coordinator: Kelly J. Shipman Administrative Assistant: Jennifer C. Coes
35 IRB Office Box 817 (617)
UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW AND REAPPROVAL OF RESEARCH
UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW AND REAPPROVAL OF RESEARCH I. PURPOSE This document outlines the required elements of University of Tennessee
More informationUNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW OF RESEARCH
UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW OF RESEARCH I. PURPOSE This document outlines the University of Tennessee Health Science Center Institutional
More informationBaptist Health Institutional Review Board. Study Closure Report (Expedited Review) IRB #: Study Title:
Baptist Health Institutional Review Board Study Closure Report (Expedited Review) (Please complete ALL sections of this form. Incomplete forms will be returned) Principal Investigator: E-mail: Phone #:
More informationUNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD PROCEDURES FOR FULL BOARD REVIEW
UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD PROCEDURES FOR FULL BOARD REVIEW I. PURPOSE This document outlines the required elements of Institutional Review Board (IRB)
More informationUNIVERSITY OF GEORGIA Institutional Review Board
UNIVERSITY OF GEORGIA Institutional Review Board Continuing Review Number: Date: Author: Approved By: Page(s): UGAHRP-057-2 01/20/2017 HSO IRB Page 1 of 7 1. PURPOSE 1.1. The UGA IRB has developed this
More informationIndependent Ethics Committees
GCP Independent Ethics Committees 1 GCP What is an Ethics Committee? An ethics committee is a committee formally designated to review and approve the initiation of a clinical research study involving human
More informationCONTINUING REVIEW 3/7/2016
DUKE UNIVERSITY HEALTH SYSTEM Human Research Protection Program Introduction CONTINUING REVIEW 3/7/2016 Federal regulations require that DUHS has written procedures which the IRB will follow for (a) conducting
More informationHuman Research Protection Program Policy
Page 1 of 6 POLICY CONTINUING REVIEW BY THE IRB The University of Cincinnati Institutional Review Board (IRB) shall conduct continuing review of human participant research at intervals appropriate to the
More informationCONTINUING REVIEW OF APPROVED IRB PROTOCOLS
POLICY # RESEARCH POLICY & PROCEDURE Approval Date: 4-13-2012 CTM c Review Cycle: 1 2 3 Revision Dates: AAHRPP DOC # 64 Responsible Office: CONTINUING REVIEW OF APPROVED IRB PROTOCOLS Research Compliance
More informationChildren s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Continuing Review of Approved Research
Page: 1 of 6 I. PURPOSE The purpose of this SOP is to describe the submission requirements for investigators and the review requirements for the IRB for the conduct of continuing review in accordance with
More informationCONTINUING REVIEW CRITERIA FOR RENEWAL
1. POLICY Steering Committee approved / Effective Date: 9/2/15 The IRB conducts continuing review of research taking place within its jurisdiction at intervals appropriate to the degree of risk, but not
More informationSignature Date Date First Effective: Signature Date Revision Date:
Revision #10 TITLE: Continuation Review Page 1 of 10 Approved By: ORI Director Signature Date Date First Effective: 05-17-05 Approved By: Nonmedical IRB Chair Signature Date Approved By: Medical IRB Chair
More informationI. Summary. II. Responsibilities
IRB Procedure 11a: Continuing Review Revision Date: May 15, 2007, revised November 11, 2009, revision July 17, 2010, revised March 1, 2011, revised February 9, 2015 I. Summary The IRB policy is to make
More informationThe Children s Hospital of Philadelphia Committee for the Protection of Human Subjects Policies and Procedures. Cooperative Agreements
Page: 1 of 8 I. PURPOSE This standard operating procedure describes the IRB s procedures for review and oversight of research conducted under a cooperative agreement with an external (outside) IRB. It
More informationOHRP Guidance on Written IRB Procedures
Office for Human Research Protections (OHRP) Department of Health and Human Services Date: OHRP Guidance on Written IRB Procedures Scope: This document outlines the required elements of written Institutional
More informationCONTINUING REVIEW CRITERIA FOR RENEWAL
1. POLICY Steering Committee approved / Effective Date: 9/2/19/19/11 The IRB conducts continuing review of research taking place within its jurisdiction at intervals appropriate to the degree of risk,
More informationIssue in IRB Approvals:
Issue in IRB Approvals: What are the obligations of investigators and the IRB in maintaining IRB approval? What are the consequences of a lapse in IRB approval? How does the IRB evaluate lapses in approval?
More informationI. Summary. II. Responsibilities
IRB Procedures 9a: Full review procedures Revision date: October 6, 2008, revision November 11, 2009, revision July 17, 2010, revised January 27, 2011, revised February 9, 2015, revised October 15, 2015
More informationTo assure knowledge and compliance by documenting the annual administrative review and continuing IRB review of non-exempt projects for the IRB.
Institutional Review Board.... University of Missouri-Columbia.. Standard Operating Procedure Annual Review of Research Annual Review of Research Effective Date: January 21, 2019 Original Approval Date:
More informationTo assure knowledge and compliance by documenting the continuing review procedure of approved projects for the IRB.
Institutional Review Board.... University of Missouri-Columbia.. Standard Operating Procedure Continuing Review Report (CRR) Continuing Review Report (CRR) Effective Date: July 1, 2004 Original Approval
More informationSOP 801: Investigator Qualifications and Responsibilities
1. POLICY University of Oklahoma : Investigator Qualifications and Responsibilities The purpose of this policy is to outline the qualifications and responsibilities of the principal investigator and key
More informationStandard Operating Policy and Procedures (SOPP) 3:
Standard Operating Policy and Procedures (SOPP) 3: INITIAL AND CONTINUING REVIEW BY THE IRB: REQUIREMENTS FOR SUBMISSION OF APPLICATIONS, APPROVAL CRITERIA, EXPEDITED AND CONVENED COMMITTEE REVIEW AND
More informationUniversity of Pennsylvania Institutional Review Board. Reliance Agreement Guidance: Post-Approval Submissions
Reliance Agreement Guidance: Post-Approval Submissions This document is designed to provide guidance on the requirements and submission processes for Amendments, Continuing Review, Reportable Events, and
More informationInvestigator Manual. If you have questions about whether an activity requires IRB review, contact the IRB Office.
CM-999 001 1 May 2015 Page 1 of 5 What is the purpose of this manual? This document is designed to guide you through policies and procedures related to the conduct of human research that are specific to
More informationLapse in IRB Approval
Office for the Protection of Research Subjects (OPRS) Institutional Review Board FWA# 00000083 Lapse in IRB Approval Version: 3.2; Date: 01/05/2016 Approved by: Human Protections Administrator, Director
More informationEffective Date: January 16, 2012 Policy Number: MHC_RP0107. Revised Date: November 2, 2015 Oversight Level: Corporate
Policy Title: Initial Review of Human Subject Research Effective Date: January 16, 2012 Policy Number: Review Date: November 20, 2015 Section: Revised Date: November 2, 2015 Oversight Level: Corporate
More information7.0 DEVIATION and EXCEPTION of a PREVIOUSLY APPROVED PROTOCOL
7.0 DEVIATION and EXCEPTION of a PREVIOUSLY APPROVED PROTOCOL 7.1 OBJECTIVE To describe the policies and procedures for reviewing a modification or a deviation/exception to a previously approved protocol.
More informationIRB Chair Responsibilities
IRB Chair Responsibilities Introduction: The Saint Luke s Health System (SLHS) Institutional Review Board (IRB) Human Research Protection Program (HRPP) is guided by the ethical principles regarding research
More informationGuidance for IRBs, Clinical Investigators, and Sponsors IRB Continuing Review after Clinical Investigation Approval
Guidance for IRBs, Clinical Investigators, and Sponsors IRB Continuing Review after Clinical Investigation Approval Additional copies are available from: Office of Communication Division of Drug Information,
More informationIRB MEETING ADMINISTRATION
1. POLICY Steering Committee approved / Effective date: 9/11/15 Except when an expedited review procedure is appropriate or an exemption determination may be made, the IRB will review proposed research
More informationSOP 5.06 Full Committee Review: Initial IRB Review
Office of Research Integrity - Human Subjects SOP #: ORI-HS(HS)- Page #: Page 1 of 5 Approved By: ORI-HS Executive Director *Signature on file Date: Date First Effective: 10/13/2016 Approved by: Biomedical
More informationSOP 407: PROTOCOL DEVIATIONS AND UNANTICIPATED PROBLEMS
University of Oklahoma Office of Human Research Participant Protection : PROTOCOL DEVIATIONS AND UNANTICIPATED PROBLEMS 1. POLICY Protocol deviations and unanticipated problems may be discovered in a variety
More informationChildren s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures. IRB Review Processes
Page: 1 of 8 I. PURPOSE II. III. IV. The purpose of this standard operating procedure is to describe IRB review processes, including pre-review, review, and post-review procedures. POLICY STATEMENT The
More informationReview of Research by the Convened IRB
Office for the Protection of Research Subjects (OPRS) Institutional Review Board FWA# 00000083 Review of Research by the Convened IRB 201 AOB (MC 672) 1737 West Polk Street Chicago, IL 60612-7227 Phone:
More informationHEALTH CARE SYSTEMS RESEARCH NETWORK
IRB APPROVAL OF HCSRN MULTI-SITE RESEARCH: FREQUENTLY ASKED QUESTIONS (AND ANSWERS) The goal of SOP HCSRN-001,, is to make human subjects review as efficient and timely as possible, while still recognizing
More informationSupersedes Document Dated: 7/7/11. SOP: RR 401 Version No.: 07 Version Date: 9/8/15 EXPEDITED REVIEW 1. POLICY
1. POLICY Steering Committee approved / Effective Date: 9/9/15 An expedited review procedure consists of a review of research involving human subjects by an IRB Chair or by one or more experienced reviewers
More informationInitial Review. Approved By: Michele Kennett, JD, MSN, LLM Associate Vice Chancellor for Research. Table of Contents
Institutional Review Board University of Missouri-Columbia Standard Operating Procedure Initial Review Initial Review Effective Date: September 1, 2004 Original Approval Date: September 1, 2004 Revision
More informationSYRACUSE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM STANDARD OPERATING PROCEDURES 02 06/30/10 08/01/07 1 OF 6
TITLE: IRB CONTINUING REVIEW REVISION NUMBER SYRACUSE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM STANDARD OPERATING PROCEDURES REVISION DATE (SUPERSEDES PRIOR VERSION) EFFECTIVE DATE DOCUMENT NUMBER:
More informationSOP #2-2 Version #1 Date First Effective: December 14, Page 1 of 6
Page 1 of 6 OBJECTIVE To describe policies and procedures for all types of protocol submissions that require review by the IRB after investigators receive initial approval. This includes protocol submissions
More informationYale University Institutional Review Boards
Yale University Institutional Review Boards 100 PR.1 Review by a Convened Institutional Review Board (IRB) Overview... 1 Meeting Dates and Distribution of Materials... 1 Materials Provided to Members for
More informationInstitutional Review Board Standard Operating Procedure. Suspension and Termination of IRB Approval
Institutional Review Board Standard Operating Procedure University of Missouri-Columbia Suspension and Termination of IRB Approval Effective Date: May 31, 2006 Original Approval Date: May 31, 2006 Revision
More informationThe IRB reviews and monitors human subjects research conducted by Columbia College Chicago faculty, staff, and students.
IRB FAQ s We hope that this FAQ will acquaint you with the basic policies and procedures of the IRB review and approval process. It is available to researchers from the Columbia College Chicago IRB. Although
More informationAMENDMENTS TO PREVIOUSLY APPROVED RESEARCH 3/01/2016
DUKE UNIVERSITY HEALTH SYSTEM Human Research Protection Program AMENDMENTS TO PREVIOUSLY APPROVED RESEARCH 3/01/2016 The Duke University Health System Institutional Review Board (DUHS IRB) requires that
More informationReporting an Unanticipated Problem Involving Risks to Subjects or Others (UPIRTSO) to the IRB
INSTITUTIONAL REVIEW BOARD (IRB) OFFICE FOR HUMAN RESEARCH PROTECTION Reporting an Unanticipated Problem Involving Risks to Subjects or Others (UPIRTSO) to the IRB UPIRTSO Flowchart Content Applies To
More informationTuesday, May 15, Please be sure to sign in and take copies of each handout.
Tuesday, May 15, 2012 Please be sure to sign in and take copies of each handout. 1 Michelle Dolske, ORA 2 Laura Orem, IRB Must be in list of Categories (see IRBNet Forms and Templates) No more than minimal
More informationSUSPENSION OR TERMINATION OF HUMAN SUBJECTS RESEARCH
P&P: RR 409 Version No:1.2 Effective Date: 11/20/2013 SUSPENSION OR TERMINATION OF HUMAN SUBJECTS RESEARCH Supercedes: CPHS Policies and Procedures 11/28/2000 1. POLICY The IRB shall have authority to
More informationUniversity of Pennsylvania Institutional Review Board. Reliance Agreement Guidance: Penn as Central IRB FAQ
Reliance Agreement Guidance: Penn as Central IRB FAQ This document is designed to answer questions frequently asked by individuals who want to know more about Penn s policies and procedures related to
More informationRESEARCH SUBMISSION REQUIREMENTS
1. POLICY IRB members rely primarily solely on the documentation submitted by investigators for initial and continuing review. Therefore this material must provide IRB members with enough information about
More informationMinot State University Institutional Review Board ANNUAL UPDATE/REVISION/PROJECT COMPLETION REPORT
Minot State University Institutional Review Board ANNUAL UPDATE/REVISION/PROJECT COMPLETION REPORT Annual Updates, Revisions, or Project Completion/Termination Reports should by typed on no more than two
More informationWayne State University Institutional Review Board
Wayne State University Institutional Review Board Subject Approvals, Serious & Continuing Non-Compliance and the Institutional Official s Responsibilities Administrative Approval: 07/2011; Office of the
More informationAdministrative Hold, Suspension, or Termination of IRB Approval
Office for the Protection of Research Subjects (OPRS) Institutional Review Board FWA# 00000083 Administrative Hold, Suspension, or Termination of IRB Approval 201 AOB (MC 672) 1737 West Polk Street Chicago,
More informationYale University Human Research Protection Program
Yale University Human Research Protection Program HRPP Policy 700 Noncompliance, Suspension and Termination Responsible Office Office of Research Administration Effective Date: February 10, 2009 Responsible
More informationScreening and Enrollment Log. List of all subjects screened and all subjects screened and enrolled in the study.
Contents Screening and Enrollment Log... 2 Regulatory Approval... 3 Protocol, Amendments and Signature Pages... 4 Investigational Product Information - 1... 5 Investigational Product Information - 2...
More informationHuman Research Protections Program Medical College of Wisconsin and Froedtert Memorial Lutheran Hospital
Human Research Protections Program Medical College of Wisconsin and Froedtert Memorial Lutheran Hospital To Whom It May Concern: The Medical College of Wisconsin (MCW) has an approved Federal Wide Assurance
More informationIRB Minutes Quality Improvement Assessment
IRB Panel Name Date of Meeting Name of Person Completing Checklist Date Completed Length of Meeting: Time Meeting Started: Time Meeting Ended: OHRP & FDA General Minutes Requirements 1. Yes No Do the minutes
More informationVersion 1. Submission Guide and Policies
Submission Guide and Policies Pearl IRB Investigator Manual Table of Contents 1.1 Pearl IRB overview... 3 1.2 What is the purpose of this manual?... 3 1.3 What is Human Research?... 3 1.4 What is the Human
More informationChapter 4 Institutional Review Board (IRB) Roles and Authorities
Chapter 4 Institutional Review Board (IRB) Roles and Authorities HSS Institutional Review Board Guidance An Institutional Review Board (IRB) is an appropriately constituted group that has been formally
More informationResearch Involving Human Subjects: AA 110.7
Research Involving Human Subjects: AA 110.7 Purpose To set forth certain human subjects rights and protections, and to establish a review process intended to ensure compliance with federal regulations
More informationCeded IRB Review. The project involves prisoners or other vulnerable populations that require special considerations.
The first assessment to make when including collaborators in research is whether the collaborating entity is engaged in research (see OHRP s Guidance on Engagement in Research). IRB oversight of engaged
More informationEXPEDITED REVIEW. Terms used in this policy, but not defined herein shall have the meanings set forth in the Glossary.
1. POLICY Steering Committee approved / Effective Date: 9/19/11 An expedited review procedure consists of a review of research involving human subjects by an IRB Chair or by one or more experienced reviewers
More informationHarford Community College. Institutional Review Board Charter and Standard Operating Procedures
Institutional Review Board Charter and Standard Operating Procedures March 5, 2010 Institutional Review Board Charter and Standard Operating Procedures TABLE OF CONTENTS INTRODUCTION...1 I. INSTITUTIONAL
More informationSYRACUSE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM STANDARD OPERATING PROCEDURES
SYRACUSE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM STANDARD OPERATING PROCEDURES TITLE: SUSPENSION OR TERMINATION OF IRB APPROVAL DOCUMENT NUMBER: 029 REVISION NUMBER 02 REVISION DATE (SUPERSEDES PRIOR
More informationWORKING WITH THE INSTITUTIONAL REVIEW BOARD &
WORKING WITH THE INSTITUTIONAL REVIEW BOARD & October 17, 2018 @ Noon (Classroom PRIVACY 8B): BOARD Diann Johnson, MPH Associate IRB Administrator October 26, 2018 @ Noon (Perrin Long Library B6-508):
More informationStudy Management SM STANDARD OPERATING PROCEDURE FOR Interactions with the Institutional Review Board (IRB)
Study Management SM 302.00 STANDARD OPERATING PROCEDURE FOR Interactions with the Institutional Review Board (IRB) Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature and Date) Approval:
More informationAn Author s Guide to Institutional Review Board (IRB)
An Author s Guide to Institutional Review Board (IRB) Why IRB is Necessary The IRB was designed to be a collegial body that helps researchers conduct responsible research. The IRB does so by weighing the
More informationNONCOMPLIANCE. 1. Overview
NONCOMPLIANCE 1. Overview Investigators, research staff, the IRBs, (ORRP), and the organization share responsibility for the ethical conduct of human subjects research and for compliance with federal regulations,
More informationUniversity of Iowa External/Central IRB Reliance Process Standard Operating Procedure (SOP)
University of Iowa External/Central IRB Reliance Process Standard Operating Procedure (SOP) I. OVERVIEW The purpose of this Standard Operating Procedure is to define a process for all University of Iowa
More informationUniversity of Pennsylvania Institutional Review Board. Reliance Agreement Guidance: How to Apply for External IRB Review
Reliance Agreement Guidance: How to Apply for External IRB Review This document provides step by step instructions on how to submit a request for the Penn IRB to rely on an External IRB using the HS-ERA
More informationCUNY HRPP Policy: Suspension or Termination of Human Subject Research
CUNY HRPP Policy: Suspension or Termination of Human Subject Research 1. Overview A UI- IRB or the Vice Chancellor for Research may suspend or terminate a research study for reasons including that: a)
More informationSOP Title Review of Research: Devices for Humanitarian Uses
SOP Title Review of Research: Devices for Humanitarian Uses Purpose This document describes the National Jewish Health IRB review of Humanitarian Use Devices and Humanitarian Device Exemptions. Scope Humanitarian
More informationEMERGENCY USE 03/02/2016
DUKE UNIVERSITY HEALTH SYSTEM Human Research Protection Program EMERGENCY USE 03/02/2016 Emergency Exemption for an Investigational Drug or Biologic or Unapproved Device Emergency use of an investigational
More informationIRB-REQUIRED INVESTIGATOR ACTIONS
Version No: 2 Effective Date: 11/01/02 Revised: 06/10/2005 09/08, 05/2009 1. POLICY IRB-REQUIRED INVESTIGATOR ACTIONS SOP: RI 801 Page 1 of 4 Between IRB initial approval of a protocol and the time of
More informationProcedure Department: HUMAN RESEARCH PROTECTIONS PROGRAM Policy Number: II.B.1
Procedure Department: HUMAN RESEARCH PROTECTIONS PROGRAM Policy Number: II.B.1 Section: HRPP Compliance Review Responsibility: HRPP Policy and Procedure Committee Original Creation Dare: November 1, 2003
More information(y9. &i?r, JUL t Certified-Return Receipt Requested WARNING LE7TER
... (y9 &i?r, DEPARTMENT OF HEALTH a HUMAN SERVICES Public Health Service Food and Drug Admini~ation Center for Biologics Evaluation and Rem 1401 Rockville Pike Rockville MD 20852-1448 JUL t 71997 Certified-Return
More informationCeded IRB Review. The University of Arizona has standing agreements in place for the following entities regarding ceded IRB review:
Investigators working at multiple institutions and with multiple IRBs may choose to have one IRB become the IRB of record over some or all participating sites (commonly referred to as ceded review, reliance
More informationCUNY HRPP Procedures: Multisite Non-Exempt Human Subjects Research
CUNY HRPP Procedures: Multisite Non-Exempt Human Subjects Research 1. Applicability These procedures apply to non-exempt multi-site research involving human subjects in which CUNY is engaged. Please refer
More informationWhat s New in GCP? FDA, OHRP Issue Harmonized Guidance on Transferring IRB Oversight of Clinical Studies
Vol. 8, No. 8, August 2012 Happy Trials to You What s New in GCP? FDA, OHRP Issue Harmonized Guidance on Transferring IRB Oversight of Clinical Studies Reprinted from the Guide to Good Clinical Practice
More informationCentralized IRB Models
Centralized IRB Models NWABR / OHRP Conference July 31, 2014 James Riddle, MCSE, CIP, CPIA Assistant Director, Institutional Review Office Fred Hutchinson Cancer Research Center Outline Central IRB s Why
More informationExpedited Review for Initial Review, Continuing Review, and Amendments
Office for the Protection of Research Subjects Institutional Review Board Expedited Review for Initial Review, Continuing Review, and Amendments 203 AOB (MC 672) 1737 West Polk Street Chicago, IL 60612-7227
More informationEffective Date: January 16, 2012 Policy Number: Appendix II. Revised Date: November 2, 2015 Oversight Level: Corporate
Policy Title: Michigan State University IRB(s) Approved Projects Effective Date: January 16, 2012 Policy Number: Review Date: December 4, 2015 Section: Revised Date: November 2, 2015 Oversight Level: Corporate
More informationEffective Date Revisions Date Review by the Convened Institutional Review Board
Review by the Convened Institutional Review Board Effective Date Revisions Date 8.1.2018 1.0 Purpose: The purpose of this standard operating practice (SOP) is to define and describe the process of review
More informationRegulations of the Institutional Review Board (IRB) (Human Subjects Committee)
Regulations of the Institutional Review Board (IRB) (Human Subjects Committee) Of the Madlyn and Leonard Abramson Center for Jewish Life 1425 Horsham Road North Wales, PA 19454 Revised and Approved: December
More informationFlorida State University IRB Standard Operational Procedures
Florida State University IRB Standard Operational Procedures 7-IRB-12 Title of Standard Operational Procedure: Cooperative Project/Multi-site projects IRB Review Responsible Executive: Approving Official:
More informationInstitutional Review Board - Restriction s Impo sed
('/(.s~ ll $L'P.VIC' s '0 ~t: 'o
More informationReliance on Independent/Central IRBs for Multicenter Clinical Trials
Reliance on Independent/Central IRBs for Multicenter Clinical Trials October 15, 2013 Outline Background New policy and process Non-IRB reviews Revised fee structure Workflow Demo of IRBIS application
More informationINSTITUTIONAL REVIEW BOARD (IRB) PROCEDURES
INSTITUTIONAL REVIEW BOARD (IRB) PROCEDURES July 2016 Table of Contents National American University Mission...2 Purposes...2 Core Values...3 Institutional Review Board Policy...4 IRB Membership...6 Training...7
More informationIRB MEETING ADMINISTRATION
1. POLICY Steering Committee approved / eeffective date: 8/31/15 4/6/11 Except when an expedited review procedure is used appropriate or an exemption determination may be madea study is deemed exempt,
More informationSignature Date Date First Effective: Signature Date Revision Date: 07/18/2011
University of Kentucky Office of Research Integrity and Institutional Review Board Revision #4 TITLE: HIPAA in Research Page 1 of 8 Approved By: ORI Director Signature Date Date First Effective: 06-10-05
More informationTitle: EXPEDITED IRB REVIEW OF HUMAN SUBJECTS RESEARCH
SYRACUSE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM STANDARD OPERATING PROCEDURES TITLE: EXPEDITED IRB REVIEW OF HUMAN SUBJECTS RESEARCH DOCUMENT NUMBER: 012 REVISION NUMBER REVISION DATE (SUPERSEDES
More informationINSTITUTIONAL REVIEW BOARD (IRB) PROCEDURES
INSTITUTIONAL REVIEW BOARD (IRB) PROCEDURES April 2013 Table of Contents National American University Mission...2 Purposes...2 Core Values...3 Institutional Review Board Policy...4 IRB Membership...6 Training...7
More informationMichigan State University Human Research Protection Program
Subject: Noncompliance Section: 9-2 Michigan State University Human Research Protection Program This policy and procedure supersedes those previously drafted. Approved by: Vice President of Research and
More information1. Review and approval of the consent document is a responsibility that FDA assigns to the IRB with jurisdiction
Medical College of Wisconsin/Froedtert Hospital Guidance on Negotiating Consent Document Language For Clinical Trial Sponsors 1. Review and approval of the consent document is a responsibility that FDA
More informationCollaborative Research
University of Hawai i HRPP Standard Operating Procedures Purpose and Scope Collaborative Research SOP 120.2 Revised: December 18, 2015 This document covers procedures for establishing IRB coverage of collaborative
More informationthe HRPP Director will prepare a draft report within three (3) workdays after the IRB meeting at which the determination occurred.
IRB Policy 34: Reporting Policy Revision Date: March 27, 2009, revised June 11, 2010, revised January 27, 2011, revised 9/23/13, revised 9/17/15, revised 4/2/18, revised 9/14/18 INSTITUTIONAL REVIEW BOARD
More informationCOMPLIANCE MONITORING
In this chapter: 3.1 Policies, Procedures, and Resources Available to Investigators and Research Staff 3.2 Investigators Conflicts of Interest (COI) -Individual Conflict of Interest Policies -Disclosure
More informationInstitutional Review Board Submission Requirement Presentation
Institutional Review Board Submission Requirement Presentation Institutional Review Board Office Dean of Graduate Studies and Research Lebanese American University OVERVIEW What is Research? Required Steps
More informationHumanitarian Use Devices Made Simple
May 25, 2017 Humanitarian Use Devices Made Simple Robert Romanchuk, BSHS, CIP, CCRC, CHRC, CCRCP IRB Vice Chairperson, Schulman IRB About Schulman IRB Established in 1983 Superior audit history with FDA
More informationPolicy Number: 42 Title: Investigational Devices Date of Last Revision: 06/12/2008; 07/22/2010; 05/29/2013; 05/01/2016; 10/16/2018
University of California, Irvine Human Research Protections Standard Operating Policies and Procedures Policy Number: 42 Title: Investigational Devices Date of Last Revision: 06/12/2008; 07/22/2010; 05/29/2013;
More informationSection 8. Continuing Review of Ongoing IRB-Approved Research (Revised 7/1/10)
Section 8 Continuing Review of Ongoing IRB-Approved Research (Revised 7/1/10) The IRB shall conduct continuing review of all research activity in compliance with 45 CFR 46 and 21 CFR 56. Continuing review
More informationDate Effective 4/21/2008 Identification
OHSU Research Integrity Office Human Research Protection Program Policies & Procedures Title: Research with Medical Devices Date Effective 4/21/2008 Identification Supersedes P&P dated: Page 1 of BACKGROUND
More information